Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
07 May 2025Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance
Antimicrobial resistance is a global health crisis, and clinical laboratories play a crucial role in detecting it. However, changing interpretive standards and increased FDA regulation have challenged the ability of these laboratories to conduct antimicrobial susceptibility testing. The FDA’s pragmatic approach to AST is a significant win for laboratories and patients.
Read more... -
06 May 2025Bibliography of Scientific Publications on Antimicrobial Resistance from South-East Asia Region (1990-2010)
Antimicrobial resistance (AMR) is a significant challenge in fighting infectious diseases, with scientific evidence supporting its emergence and persistence. A bibliography of technical publications in English is compiled to help Member States understand trends and expertise.
Read more... -
06 May 2025Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia
Antimicrobial resistance (AMR) is a global crisis causing 8.22 million deaths annually by 2050. Asia faces the threat due to antibiotic overuse, poor health systems, and climate vulnerabilities. A strategic response involving education, prevention, monitoring, and long-term marathons could save $55 billion annually by the next decade. This paper encourages private funders, impact investors, and […]
Read more...
More news related to Healthy patients
